Location: Home
  • search
  • go
  • Relate News
  • 1/10/2023AmMax and Evopoint Enter into an Exclusive Option Agreement to License...
  • 1/9/2023NMPA Announces Package Insert Revision of Ibandronate Sodium Inj and T...
  • 1/9/2023Simnova and Orna Thera Collaborate to Advance Orna's Next Gen Circular...
  • 1/9/2023Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...
  • 1/6/2023Top The Chinese Pharma In-licensing Deals in 2022 (PharmCube)
  • 1/6/2023Top Ten Chinese Biopharma Out-licensing Deals in 2022 (PharmCube)
  • 1/6/2023CDE Solicits Comments on the Technical Guidelines for R&D of TCM Impro...
  • 1/6/2023CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M11
  • 1/6/2023China Issues Two New Policies on BMI Reimbursement of Covid Hospitaliz...
  • 1/6/2023Recent Executive Moves
  • 1/5/2023GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...
  • 1/5/2023CANbridge Consolidates Gene Therapy Portfolio by Exercising License Op...
  • 1/5/2023NMPA Holds National Drug Regulatory Conference in Beijing
  • 1/5/20232022 NRDL Access Negotiation Reinitiated with Industry Hoping for "Mod...
  • 1/5/2023Aurisco to Build Oligonucleotides Manufacturing Facility in China
  • 1/5/202320 Promising New Drugs Anticipated To Be Approved in China 2023 (Pharm...
  • 1/4/2023NHC and SATCM Announce Action Plan for the Overall Pain Management Tri...
  • 1/3/2023Fosun Pharma and Henlius Entered into an Exclusive License Agreement f...
  • 12/30/2022Merck's COVID Drug Molnupiravir Conditionally Approved in China
  • 12/30/2022Abbott to Exit China's Pediatric Nutrition Market
  • 12/30/2022Recent Executive Moves
  • 12/30/2022Financial-related Company News Digest (December 2022)
  • 12/29/2022NMPA Participates in the CIMDR - GHWP Session & International Drug Reg...
  • 12/29/2022NMPA Issues the Provisions on Facilitating Main Responsibility of MAHs...
  • 12/28/2022InnoCare Receives Approval of Tafasitamab in Combo with Lenalidomide f...
  • 12/28/2022Everest Medicines Begins Operations at mRNA Vaccine Production Site in...
  • 12/27/2022Antengene and Merck Enter into a Global Clinical Collaboration with M...
  • 12/26/2022NHSA Announces Comprehensive Inspection of Irregular BMI Coverage Rest...
  • 12/26/2022Hikma and Junshi Sign Exclusive Licensing Pact for Anticancer Toripali...
  • 12/26/2022Deloitte: 2023 China LSHC Investment and M&A Market Outlook
  • Page:32/333 Total number of articles:9989: [First][<<] [30] [31] [32] [33] [34] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group